SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.

In some cases, healthcare providers may prescribe up to 2 mg once weekly. Ozempic should be injected subcutaneously in the abdomen, thigh, or upper arm. It is important to follow a consistent ...

Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by ...

Wegovy is also available through NovoCare Pharmacy, which directly ship all dose strengths at a cost of $499 per month for ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

In studies of Ozempic for type 2 diabetes, 20.3% of participants taking a 1-milligram (mg) dose of Ozempic reported feeling nauseous, compared to 6.1% of those given a placebo. Higher doses are ...

The announcement came as Novo Nordisk announced it was expanding its offer for cash-paying patients to access to its Wegovy (semaglutide) injection 0.25 mg ... obesity drugs Ozempic and Wegovy ...

NanoPortal™ technology successfully delivers semaglutide, the active ingredient in Ozempic®/Wegovy®, in a preclinical study ...